Walgreens Boots Alliance, Inc. logo
WBAWalgreens Boots Alliance, Inc.

The forward PE ratio is 7.65 as of Thursday, July 9, 2026.

Forward PE Ratio (7.65) = Close Price ($11.98) / Consensus Forward EPS ($1.57)

WBA Forward PE Ratio Metrics

FORWARD PE RATIO

7.65

WBA Competitors' Forward PE Ratio

WBA

Walgreens Boots Alliance, Inc.

Current

Market Cap

$10.37B

Forward PE Ratio

7.65

TEM

Tempus AI, Inc.

vs WBA

Market Cap

$10.73B

Forward PE Ratio

N/A

PODD

Insulet Corp.

vs WBA

Market Cap

$10.96B

Forward PE Ratio

24.29

UHS

Universal Health Services, Inc.

vs WBA

Market Cap

$9.72B

Forward PE Ratio

6.66

TECH

Bio-Techne Corporation

vs WBA

Market Cap

$11.14B

Forward PE Ratio

36.89

HSIC

Henry Schein, Inc.

vs WBA

Market Cap

$9.55B

Forward PE Ratio

15.56

CRL

Charles River Laboratories International, Inc.

vs WBA

Market Cap

$11.25B

Forward PE Ratio

20.18

BAX

Baxter International Inc.

vs WBA

Market Cap

$11.60B

Forward PE Ratio

11.45

MOH

Molina Healthcare, Inc.

vs WBA

Market Cap

$12.09B

Forward PE Ratio

45.00

RVTY

Revvity, Inc.

vs WBA

Market Cap

$12.60B

Forward PE Ratio

20.86

Trailing vs Forward

Trailing P/E

N/A

reported TTM EPS

Forward P/E

7.7

consensus next-FY EPS

Forward P/E by Fiscal Year

View All Analyst Estimates

At today's $11.98 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.

Fiscal year endConsensus EPSEstimate rangeAnalystsImplied P/E
2026-08-31$1.57$1.13 – $1.7357.6x
2027-08-31$1.67$-0.37 – $2.7837.2x
2028-08-31$1.80$1.66 – $1.8916.7x

Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.

Forward PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Forward PE Ratio FAQ

What is the forward PE ratio for Walgreens Boots Alliance, Inc. (WBA)?
The forward PE ratio for WBA stock is 7.65.

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.

Deerfield, IL
193,000 employees
Healthcare / Medical - Pharmaceuticals
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Timothy C. Wentworth